Inpatient Buprenorphine Initiation for Pregnant Patients
Due to the opioid epidemic, pregnancy-related overdose deaths have risen significantly and are becoming a leading cause of maternal mortality. Medications for opioid use disorder decrease mortality. Despite the American College of Obstetricians and Gynecologists' recommendation to treat OUD with MOUD during pregnancy, many health care professionals lack the education and tools to initiate MOUD for pregnant patients with active substance use.
Authors
- Daisy Goodman (ORCID: https://orcid.org/0000-0002-2402-6251)
- Katherine Stokes
- Robert Blatman
- Ashley K. Johnson
- Amy Lee (ORCID: https://orcid.org/0000-0002-4853-578X)
- Jeffrey Low (ORCID: https://orcid.org/0000-0002-1992-7389)
Institutions
- Dartmouth–Hitchcock Medical Center (US)
Publication Details
- Journal
- Obstetrics and Gynecology
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1097/aog.0000000000005868
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American College of Obstetricians and Gynecologists